Abstract
Introduction
Long QT syndrome (LQTS) is one of the heart's primary electrical disorders, predisposing the affected individuals to sudden cardiac death caused by ventricular arrhythmias. The prolonged (usually >480ms) corrected QT interval (QTc) in these patients is caused by a delayed repolarization of the cardiac action potential (AP). Many genes are associated with LQTS: the KCNQ1 gene, which causes LQTS type 1 (LQTS1), accounts for more than 30% of the identified pathological genetic variants and mutations in LQTS. The KCNQ1 gene codes for K V 7.1 channels which, after assembly with KCNE1 subunits, generate the slow delayed rectifier potassium current(I Ks ) that greatly contributes to the repolarization of the cardiac AP [1] .
I Ks becomes predominant at fast heart rates due to the slow deactivation kinetics, leading to an accumulation of K V 7.1-KCNE1 channels in the activated-closed state, facilitating channel opening when required [2] . The finding that exercise and emotional stress trigger arrhythmias in more than 80% of the LQTS1 patients demonstrates the key role of this current during elevated heart rates [3] .
The KCNQ1 mutation D242N was found in two patients (twins) with LQTS [4] . Experimental data show that mutant channels generate a smaller current at physiological membrane potentials, supporting the currents' major role in the LQTS phenotype of the patients.
In this study, we identify an I Ks computational model which fits the experimental electrophysiological data and use it to investigate the effects of the biophysical and cellular phenotype of the mutation D242N on the AP and the pseudo-ECG using the O'Hara-Rudy (ORd) human cardiac AP model.
Methods
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Two 20-year-old dizygotic twins (one female and one male) were evaluated after presenting with episodes of syncope and one nocturnal seizure pre-diagnosis. Both twins were genetically examined and found to carry the KCNQ1 mutation D242N (chr11:2572053G>A, c.724G>A), localized in the exon 5.
To examine the D242N effects in the physiologically relevant K v 7.1 channel complex, the wild type (WT) K v 7.1 and the mutant D242N subunits were cotransfected with KCNE1.
Membrane currents were measured from transiently transfected COS7 cells using the perforated-patch configuration of the patch-clamp technique with amphotericin and recorded using an Axopatch 200B amplifier (Axon Instruments) as described in Moreno et al.'s 2015 work [5] . Currents were recorded at room temperature (21-23ºC) at a stimulation frequency of 0.03 Hz.
Computational analysis
To evaluate the electrophysiological consequences of the D242N mutation at the cardiac AP level, we used the ORd human ventricular model [6] . We fitted a new I Ks formulation, based on data obtained in WT and D242N channels for the steady state activation parameters (V h and s, see followed equations) and the deactivation time constant (see Figure 2 ). Since the ORd I Ks formulation includes a square value of the gating variable xs, its time constant was doubled with respect to the fitted experimental values. Finally, the activation time constant and maximal conductance were tuned to reproduce the voltage-clamp recordings of K V 7.1 current in the presence of KCNE1, both in WT and mutant heterozygous conditions at room temperature (Figure 2) , and to obtain, in WT, the same peak current during the AP as in the ORd original model.
The scaling factor Q10=3 [5] was used to scale the I Ks time constant from room temperature (23°C) to physiological (36°C). The β-adrenergic stimulation was simulated according to the computational study of Severi et al. [8] by increasing I Ks (scaled by a factor of 2.66), I CaL (scaled by a factor of 1.5), and I up (scaled by a factor of 1.5)-and by manipulating the time constant. In order to speed up deactivation and slow down activation ( [7] [8] ), the constant was decreased for negative potentials and increased for positive potentials (see Figure 2) . The I Ks formulation used in the AP simulations is: Single cell simulations. Model differential equations were implemented in Matlab (Mathworks Inc., Natick, MA, USA) and solved with a variable-order solver (ode15s). Pacing at the same experimental frequencies was maintained until a steady state AP was reached, and the AP duration (APD) was measured as the interval between the AP upstroke and the 90% repolarization level (APD 90 ).
Multicellular simulations. A one-dimensional fiber (1.64 cm length) composed of 25 endo-, 30 M-, 50 midand 60 epi-cardial cells was simulated [9] . Midmyocardial cells were modeled with intermediate (between endo-and epi-) parameter values; the pseudo-ECG signal was computed upon pacing of the endocardial end of the tissue as previously described [10] , using intracellular and extracellular conductivity of 2ms/cm and 8ms/cm, respectively.
Model equations were translated into cellML language in the COR environment, and monodomain equations were solved with Chaste Software [11] .
Results
Electrophysiological results
The patients' heterozygous conditions were mimicked by expressing 50% of the mutant channels. Figure 1 (black) shows the experimental average of the WT and D242N traces obtained after applying the pulse protocol (shown at the top). The activation curves for mutant channels are mildly shifted toward positive potentials with respect to the WT channels. Additionally, the deactivation kinetics were faster for mutant channels than WT channels (313.8±89.2ms vs. 513.6±37.0ms, n=5/15, P<0.05) (Figure 2) . 
Computational results
The results of the I Ks model identification based on the experimental data are shown in Figure 1 , panels C and E.
The ORd human ventricular cell model with the new I Ks formulation (see Methods) was used to examine the effects of the heterozygous condition on AP morphology in endocardial, epicardial, and M cells (only M cells are reported in Figure 3 ). At the basal rate (60bpm), the mutation had a negligible effect on all cell types. In contrast, at the higher rate (180bpm) with concomitant β-adrenergic stimulation (mimicking exercise conditions) the mutant AP failed to adapt its duration to the same extent as the WT AP (e.g. 281 vs. 267ms in M cells, Figure 3 , top panel) due to a smaller amount of I Ks current (Figure 3, middle panel) . The impaired rate adaptation exhibited by the mutant was also evident when the rate dependence curve was computed (APD 90 vs. pacing cycle length, changing the % of β-adrenergic stimulation: no β-adr at CL=1000ms, 25% at CL=700ms, 50% at CL=500ms, 75% at CL=400ms and 100% at CL=333ms) ( Figure 3, bottom panel) .
At the cardiomyocyte level, the I Ks current amplitude increases with heart rate and β-adrenergic stimulation. Our simulation results suggest that both factors contribute equally to exercise adaptation since if rate is increased with no β-adrenergic stimulation, a small decrease in APD adaptation is observed (e.g. WT: from 356 to 298 ms, D242N: from 359 to 305 ms, at 180 bpm), and a similar effect is produced by simulation of β-adrenergic stimulation alone with no change in rate (WT: from 298 to 267 ms, D242N: from 305 to 281 ms).
In order to relate the modeled changes in APD 90 to QTc, we computed pseudo-ECGs for heterozygous conditions. In Figure 4 , the results of simulations run at exactly the same heart rates experimentally recorded in twin #1 at baseline and under exercise (84bpm vs. 163bpm plus β-adrenergic stimulation) are shown. Only a slight rate adaptation is observed, and the simulated QTc was significantly prolonged from 387ms to 493ms, similarly to experimental recordings. 
Discussion and Conclusion
The electrophysiological results suggest that, in cardiomyocytes, this mutation induces a delay in the repolarization phase of the cardiac AP. The delay ultimately triggers the prolongation of the QT interval, leading to the almost complete loss of adaptation to high heart rates which is detected in D242N-LQTS1 patients.
The computational analysis confirmed that these mutant channels cannot respond properly to heart rate changes. It also provided a plausible explanation for the clinical manifestations of the mutation (only a slight decrease in the QT interval during exercise, with a consequent great increase in the QTc). While the mutation has negligible effects on the AP at baseline, a failure to adapt to exercise conditions was identified. 
